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Background: Lung inflammation is a major consequence of the systemic inflammatory response caused by
severe sepsis. Increased migration of γδ T lymphocytes into the lungs has been previously demonstrated during
experimental sepsis; however, the involvement of the γδ T cell subtype Vγ4 has not been previously described.
Methods: Severe sepsis was induced by cecal ligation and puncture (CLP; 9 punctures, 21G needle) in male C57BL/
6 mice. γδ and Vγ4 T lymphocyte depletion was performed by 3A10 and UC3-10A6 mAb i.p. administration,
respectively. Lung infiltrating T lymphocytes, IL-17 production and mortality rate were evaluated.
Results: Severe sepsis induced by CLP in C57BL/6 mice led to an intense lung inflammatory response, marked by the
accumulation of γδ T lymphocytes (comprising the Vγ4 subtype). γδ T lymphocytes present in the lungs of CLP mice
were likely to be originated from peripheral lymphoid organs and migrated towards CCL2, CCL3 and CCL5, which were
highly produced in response to CLP-induced sepsis. Increased expression of CD25 by Vγ4 T lymphocytes was observed
in spleen earlier than that by αβ T cells, suggesting the early activation of Vγ4 T cells. The Vγ4 T lymphocyte subset
predominated among the IL-17+ cell populations present in the lungs of CLP mice (unlike Vγ1 and αβ T lymphocytes)
and was strongly biased toward IL-17 rather than toward IFN-γ production. Accordingly, the in vivo administration of
anti-Vγ4 mAb abrogated CLP-induced IL-17 production in mouse lungs. Furthermore, anti-Vγ4 mAb treatment accelerated
mortality rate in severe septic mice, demonstrating that Vγ4 T lymphocyte play a beneficial role in host defense.
Conclusions: Overall, our findings provide evidence that early-activated Vγ4 T lymphocytes are the main responsible
cells for IL-17 production in inflamed lungs during the course of sepsis and delay mortality of septic mice.
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Mortality induced by sepsis is highly associated with second-
ary acute lung injury. Systemic inflammation during sepsis
leads to acute respiratory distress syndrome (ARDS) caused
by an exacerbated response of the immune system to bac-
teria and their products [1–4]. Indeed, mice subjected to* Correspondence: cpenido@cdts.fiocruz.br
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article, unless otherwise stated.experimental model of sepsis induced by cecal ligation
and puncture (CLP) show deregulation in pulmonary im-
mune response, marked by cytokine storm and intense ac-
cumulation of activated leukocytes in lung tissue,
including T lymphocytes [5–8].
γδ T lymphocytes are unconventional lymphocytes
that have antigen recognition properties fundamentally
different from those of αβ T lymphocytes, and are com-
prised by distinct functional subsets, defined by the dif-
ferential usage of Vγ and Vδ gene repertoire [9, 10]. The
Vγ4 T lymphocyte subset is highly associated with lung
immune surveillance and increases in number in mouse
lungs at early time points during bacterial infections
[10–13]. Increased migration of γδ T cells into the lungsCentral. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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sepsis; however, the identification of γδ T cell subtypes
has not been previously described [7, 8, 14].
The migration of γδ T lymphocytes is largely dictated
by the activation of chemokine receptors by their coun-
terpart ligands, among which members from both CC
and CXC subfamilies play compelling roles [15–17].
Once at the infection site, these cells can rapidly re-
spond to microbial antigens via innate surface receptors
[18–21], producing high amounts of interferon (IFN)-γ
and interleukin (IL)-17, which are signature cytokines
produced by specific subsets of γδ T cells [22–26]. Vγ4
T lymphocytes represent one of the major subsets that
produce IL-17 in different experimental models [27–30].
γδ T lymphocytes have been shown to play divergent
roles in mouse models of sepsis [8, 14, 31–34]. The pro-
tective role of γδ T lymphocytes during experimental
sepsis has been attributed to the production of IL-17, a
cytokine that triggers neutrophil recruitment and im-
proves bacterial clearance [33, 35–37]. Furthermore, the
accumulation of activated γδ T lymphocytes in the lungs
of CLP mice has been correlated with beneficial out-
come of septic mice [8, 14]. Here we show that during
the course of experimental severe sepsis, Vγ4 T lympho-
cytes migrate into injured lungs of CLP mice and exert a
protective role via the production of IL-17.
Results
Activated γδ T lymphocytes accumulate in mouse lungs
during severe sepsis
The induction of severe sepsis triggered an intense inflam-
matory response in mouse lungs, marked by a significant
increase of γδ and αβ T lymphocyte numbers observed
from 1 to 10 days after the surgery (Fig. 1a-c). The γδ T
cell subtype Vγ4 also infiltrated into the lungs of CLP-
induced mice and, differently from those of αβ and γδ T
lymphocytes, did not decrease in numbers at day 3 post-
surgery. Both γδ and αβ T lymphocyte numbers were
decreased in mouse spleen from 1–3 days after CLP,
returning to control (sham-operated mice) levels within
10 days (Fig. 1d-f), suggesting that T cells found in the
lungs egress from secondary lymphoid organs.
The analysis of activation marker expression revealed
that the presence of CD25+ T lymphocytes in the lungs
and spleen of CLP mice was more expressive among γδ
rather than among αβ T cell population. The percent-
ages of γδ (and Vγ4+) T lymphocytes expressing CD25
were increased in the lungs of CLP mice at day 3 post
CLP and persisted elevated until 10 days after surgery,
when the number of αβ T lymphocyte also increased
(Fig. 2a-c). In spleens, γδ and Vγ4 T lymphocytes were
constantly activated during the course of experimental
severe sepsis, whereas CD25+ αβ T lymphocytes were
only elevated at day 3 after CLP (Fig. 2d-f ).γδ T lymphocytes migrate from spleen into the lungs of
CLP-operated recipient mice coordinated by lymphotactic
chemokines
Ten days after surgery, CFSE+ γδ (but not αβ) T cells
adoptively transferred from naïve mice were preferen-
tially localized in the lungs of CLP-operated mice, when
compared to blood and spleen (Fig. 3a-f ). In accordance,
increased levels of CCL2, CCL3 and CCL5 were detected
in lung homogenates of CLP-operated mice, when com-
pared to chemokine levels detected in naïve and sham
mouse lung samples (Fig. 3g). No differences were ob-
served in CCL25 levels between CLP- and sham-
operated mice (sham 681 ± 94; CLP 753 ± 175 pg/lung).
γδ T lymphocytes migrated in vitro towards lung ho-
mogenates obtained from CLP mice at a higher extent
than towards lung homogenates from naïve or sham-
operated mice. The in vitro neutralization of CCL2,
CCL3 and CCL5 by mAbs inhibited γδ T lymphocyte
chemotaxis towards the respective chemokines and lung
homogenates obtained from CLP mice, suggesting that
these chemokines coordinate γδ T cell in vivo migration
into the lungs during severe sepsis (Fig. 3h).
γδ T lymphocytes from the lungs of CLP-operated mice
produce IL-17
Ten days after surgery, intracellular staining revealed
that the percentage of IL-17+ γδ T lymphocytes in-
creased among total CD3+ cell population in the lungs
of CLP mice, while the percentage of IL-17+ αβ T lym-
phocytes decreased after CLP, when compared to sham-
operated mice (Fig. 4a). Evaluation of γδ T cell cytokine
profile revealed a slight decrease in IL-10+ and IFN-γ+
γδ T lymphocytes in CLP mouse lungs, whereas no dif-
ferences between IL-4+, IL-12+ or tumor necrosis factor
(TNF)-α+ γδ T lymphocytes were detected between CLP
and sham mice (Additional file 1: Figure S1A). It is note-
worthy that the percentage of IL-17+ (but not IFN-γ+)
γδ T lymphocytes increased upon in vitro restimulation
with α-CD3 mAb (Additional file 1: Figure S1B-C).
Representative dot plots show that IL-17 positive stain-
ing was detected among γδ+ and Vγ4+, but not among
the Vγ1+ lymphocyte subtype recovered from the lungs
of CLP mice (Fig. 4b). IL-17 production by γδ T cells
is restricted to CD27- cells. Accordingly, our data
demonstrate that the percentage of CD27- lymphocytes
increased among Vγ4+, but not among the Vγ1+ lym-
phocytes in the spleen 3 days after CLP (Fig. 4c-d). To
evaluate the implication of Vγ4 T lymphocytes in IL-
17 production during sepsis, mice were treated with
anti-Vγ4 mAb 1 day before CLP. Figure 4e shows that
anti-Vγ4 mAb treatment decreased IL-17 production
in CLP mouse lungs 7 days after surgery, in a similar
extent as γδ T lymphocytes.
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C57BL/6 mice subjected to severe sepsis
Approximately 50 % of C57BL/6 mice subjected to the ex-
perimental model of severe sepsis and antibiotic treatment
died within 7 days (Fig. 5a). Anti-Vγ4 mAb treated mice
that underwent CLP died in shorter periods of time,
achieving 30 % of survival rate within 7 days. Worthy of
note, anti-γδ mAb treatment similarly precipitated CLP
mouse death, suggesting that Vγ4 T cell subset presents aFig. 1 γδ T lymphocytes accumulate in mouse lungs and spleen after CLP. γδ
spleen (d–f) 1, 3 and 10 days after CLP. Results are expressed as mean ± SEM
Statistical differences between the CLP and sham group (p < 0.05) are indicateprotective role in septic mice. IgG isotype-treated mice
showed similar survival rate than untreated mice. Figure 5b
and Additional file 2: Figure S2A–B show the effectiveness
of depletion by mAb administration in spleen and lungs.
Discussion
Sepsis triggers a complex immune response that involves
both innate and adaptive systems. γδ T lymphocytes rep-
resent a link between these two branches of the immune, Vγ4 and αβ T lymphocyte numbers in C57BL/6 mouse lungs (a–c) and
from at least five animals per group out of three different experiments.
d by (*). The gates were set according to IgG isotype staining
CD25  T cells+
Fig. 2 Activated γδ T lymphocytes accumulate in mouse lungs and spleen after CLP. Percentages of CD25+ cells among γδ, Vγ4 and αβ T lymphocyte
populations recovered from mouse lungs (a–c) and spleen (d–f) 1, 3 and 10 days after CLP. Results are expressed as mean ± SEM from at least five
animals per group out of three different experiments. Statistical differences between the CLP and sham group (p < 0.05) are indicated by (*). The gates
were set according to IgG isotype staining
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populations via cytokine production [27]. γδ T lympho-
cytes have been described as a major source of IL-17 in
peritoneum and lymphoid organs during experimental
sepsis, a phenomenon shown to present either beneficial
or deleterious effects, depending on the experimental
model [33–35, 38]. The data presented here identifies
the Vγ4 subset as a dominant producer of IL-17 in the
lungs of septic mice and as a central T cell population
involved in host defense against sepsis.
The experimental model of severe sepsis used in the
present work resulted in the accumulation of T lympho-
cytes in lung tissue, which were likely originated from
lymphoid organs. Increased numbers of both γδ and αβT lymphocyte subsets were detected in the lungs; how-
ever it is noteworthy that, differently from αβ T lympho-
cytes, γδ T cell numbers continually increased up to day
10 after CLP, mainly due to the accumulation of Vγ4
subset. The progressive accumulation of γδ T cells in the
lungs of CLP-operated mice has been previously demon-
strated by Hirsh and coworkers [7]; however, the pres-
ence of γδ T cell subtypes has not been described. The
decrease in αβ T cell numbers observed at day 3 after
CLP is in accordance with several reports in mice and
humans that demonstrate a reduction in circulating
CD3+ T lymphocytes during sepsis [39]. This reduction
is explained by a massive apoptotic event of T lympho-





Fig. 3 (See legend on next page.)
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Fig. 3 γδ T lymphocytes migrate from spleen into the lungs of CLP-operated recipient mice. T lymphocytes recovered from the spleen of naïve
mice were labeled with CFSE and transferred to CLP-operated mice 3 and 8 days after surgery. Recipient animals were euthanized 10 days after
surgery, and their lungs, blood and spleen were collected for γδ (a–c) and αβ (d–f) T cell analysis by flow cytometry. Quantification of CCL2,
CCL3, and CCL5 levels in lung homogenates of naïve, sham and CLP C57BL/6 mice by ELISA, 7 days after surgery (g). γδ T cell chemotaxis towards
lung homogenates from CLP mice (or towards CCL2, CCL3 and CCL5), incubated or not with neutralizing α-CCL2, α-CCL3 or α-CCL5, as described
in methods (h). Representative results of two experiments from at least 4 animals per experimental group are expressed as mean ± SEM. Statistical
differences (p < 0.05) between CLP and sham groups are indicated by (*), and between stimulated and mAb-treated groups are indicated by (+)
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that the percentage of CD25+ T lymphocytes increased
among γδ T lymphocytes in the lungs at early time
points after CLP (day 1) suggests that γδ (but not αβ) T
lymphocytes are constantly activated in lymphoid tis-
sues during the course of sepsis and continuously mi-
grate towards inflamed lungs. In accordance with our
data, Matsushima and co-workers [40] demonstrated
the early activation of γδ T lymphocytes from periph-
eral blood of patients with sepsis and systemic inflam-
matory response syndrome. These patients presented
increased percentages of peripheral CD69+ γδ T cells at
acute time points after injuries, whereas CD69 expression
by αβ T cells did not increase during a 2-week period [40].
It is noteworthy that, in our study, such early activation
was also evident for Vγ4 T cell population, as observed in
mouse spleen and lungs 1 day after CLP.
The selective migration of γδ T lymphocyte subsets
into the tissue during inflammation is dictated by ele-
vated levels of chemoattractant mediators in the tissue
and by the expression pattern of chemokine receptors
on cell surface [9, 10, 15, 16, 42, 43]. Our results suggest
that γδ and Vγ4 T cell migration into the lungs of CLP
mice is likely accounted by the combined in situ accu-
mulation of multiple chemokines. CLP-induced lung in-
flammation increased tissue levels of CCL2, CCL3 and
CCL5, chemokines that are known to mediate γδ T
lymphocyte migration in vivo and in vitro [44–47]. Con-
sistently, here we show that adoptively transferred γδ T
cells preferentially accumulated in the lungs (rather than
in blood or spleen) of recipient CLP mice. Even though
CCL2, CCL3 and CCL5 are also chemoattractant for αβ
T lymphocytes [48], the neutralization of these chemo-
kines in CLP lung homogenates did not impair the
chemotaxis of γδ- T lymphocytes (data not shown), sug-
gesting that these chemokines selectively dictate the
migration of γδ T cells into the lungs in our model. The
involvement of CCL25 in γδ T cell migration towards
inflamed lungs during sepsis was also investigated by us,
since CCL25 has been shown to attract IL-17+ γδ T cells
into inflamed airways [15]. However, CCL25 was not
enhanced in CLP mouse lungs (data not shown).
Our data demonstrate that the Vγ4 T lymphocyte subset
predominated among the IL-17+ cell populations in CLP
mouse lungs. In line with this, it has been demonstratedthat mice lacking γδ T cells (but not αβ T cells) subjected
to CLP failed to present elevated IL-17 levels in the
plasma and peritoneal lavage, showing that γδ T cells are
the major producers of IL-17 during experimental sepsis
[33–35, 38]. It has been established that, among murine
γδ T lymphocytes, IL-17 production is restricted to Vγ4
and Vγ6 subtypes [27, 49]. Consistently with our data,
Vγ4 T lymphocytes comprise the major subset that mi-
grates into the lungs and have been shown to produce
IL-17 in different experimental models [10, 13, 24–30].
It is noteworthy that our supplemental data (Additional
file 1: Figure S1A) demonstrate that IL-17 production
by γδ T cells from CLP-mouse lungs predominated over
the expression of other cytokines, including IFN-γ.
These data are reinforced by the increase in the per-
centage of CD27- γδ+ (and Vγ4+) population in CLP-
mouse spleen and by the fact that, upon α-CD3 mAb in
vitro stimulation, these cells were enriched for IL-17
but not for IFN-γ (Additional file 1: Figure S1B–C).
Increased numbers of γδ T lymphocytes in the blood,
peritoneum and lungs have been correlated with sepsis
positive outcome in patients and experimental animals
[8, 14, 32, 35, 50]. Indeed, mice lacking γδ T lympho-
cytes and subjected to CLP presented increased mortal-
ity rate and decreased survival periods [14, 32]. The
protective role of γδ T lymphocytes during sepsis results
from the ability of these cells to produce inflammatory
mediators capable to modulate other leukocyte popula-
tions, among which IL-17 is of particular importance
[35, 51, 52]. Here we show that IL-17 production in the
lungs of CLP mice depends on infiltrated Vγ4 γδ T cell
subset, which likely contributes to host protective im-
mune response. Since adverse roles have been proposed
for IL-17 during experimental sepsis, the effect of IL-17
in the lungs of CLP mice needs further investigation. It
has been described that IL-17 derived from γδ T cells
promotes epithelial repair in different tissues [53–55],
suggesting that IL-17 produced by Vγ4 T cells might act
on lung epithelium, promoting tissue repair and amelior-
ating mouse illness after CLP [33–35, 56]. IL-17 has also
been associated with neutrophil influx into inflamed
tissue, which can lead to either protective or harmful
outcomes [35, 37, 57, 58]. Concerning lung immune
response, effective bacteria clearance by neutrophils re-
duces the risk of lung failure [36]; however, it is well
Fig. 4 Increased IL-17 production by Vγ4 T lymphocytes in CLP mouse lungs. a Percentages of γδ and αβ T lymphocytes among lung IL-17+ T
cells recovered 10 days after CLP, as determined by intracellular staining. b Representative dot plots of intracellular staining of IL-17+ within γδ,
Vγ4 and Vγ1 T cells recovered from the lungs of CLP mice. c Percentages of CD27- cells among γδ, Vγ4 and Vγ1 T cell population in the spleen
recovered 3 days after CLP. d Representative histograms of CD27 staining of γδ, Vγ4 and Vγ1 T cells recovered from mouse spleen. e IL-17 quantification
in lung homogenates of CLP mice treated or not with α-γδ TCR mAb, α-Vγ4 TCR mAb or control IgG, 7 days after surgery was performed by CBA. Results
are expressed as mean ± SEM from at least 5 animals per group. Statistical differences (p < 0.05) between CLP and sham groups are indicated by (*), and
between stimulated and mAb-treated groups are indicated by (+)
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duction of myeloperoxidase (MPO) can cause tissue
damage [57]. In our study, we observed increased neutro-
phil numbers in the lungs of CLP mice, which was sig-
nificantly reduced after anti-Vγ4 mAb treatment (data
not shown), suggesting neutrophil involvement in the
resolutive response. The involvement of tissue-recruited
neutrophils coordinated by IL-17+ γδ T cells in tissue re-
pair has been demonstrated in different experimental
models. γδ T cell knockout (KO) mice submitted to
inflammatory insults are shown to present reduced neu-
trophil and MPO accumulation in the lungs, liver and
cornea, which correlated with increased lesions and
delayed epithelial regeneration [53–55]. Moreover, in amodel of corneal epithelial abrasion, it was demonstrated
that γδ T cells induced, via IL-17, the production of vas-
cular endothelial growth factor (VEGF) by neutrophils,
promoting corneal nerve regeneration [59]. Our study
evidenced that IL-17+ Vγ4 T lymphocytes migrate into
injured lungs of CLP mice, presenting a beneficial role
during the course of sepsis.
Conclusions
In the present work, we show that early-activated Vγ4
T lymphocytes continuously accumulate in inflamed
lungs during the course of sepsis and that local IL-17
production depends on the tissue infiltration of this
subset, which preferentially produces this cytokine.
Fig. 5 Anti-Vγ4 mAb treatment decreases survival rate of septic mice. a Survival rate was analyzed in CLP mice treated or not with α-γδ TCR
mAb, α-Vγ4 TCR mAb or IgG up to 7 days after CLP surgery. The results are expressed as percentage of survival rate per day, from 10 mice per
group. b Representative dot plots of γδ and Vγ4+ T cell frequency in spleen and lungs of treated mice, analyzed by flow cytometry
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lymphocytes contribute to the protective immune
response of septic mice and delay mortality. Further
complementary investigation concerning cellular and
molecular mechanisms of Vγ4 T cell/IL-17 pathway
associated with protection during sepsis is of extreme
value to bring new insights to approach novel targets
and therapies.
Methods
Cecal ligation and puncture
Polymicrobial sepsis was induced by cecal ligation and
puncture (CLP) in normal fed and anesthetized (112.5 mg/
kg of ketamin and 7.5 mg/kg of xylazine, i.p. Rhobifarma,Brazil) male C57BL/6 mice (18 to 20 g) provided by
Oswaldo Cruz Foundation breeding unit (Rio de Janeiro,
Brazil). After laparotomy (incision of 0.5–1 cm), the
cecum was ligated with a cotton suture distal to the ileo-
cecal valve to avoid bowel obstruction, and punctured
nine times with a 21-gauge needle. The cecum was placed
back into the abdomen and the incision was closed by a
4–0 polyamide suture. Sham-operated animals received
midline laparotomies, exteriorization of the cecum with
its immediate return and closure of incisions. Mice were
resuscitated by a subcutaneous injection of 1 ml sterile
saline solution. Mice were treated with ertapenem (Merck,
Germany; 75 mg/kg, i.p.) 6, 24 and 48 h after surgery. For
lung analysis, mice were euthanized in a CO2 chamber 1,
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of survival rate, mice were evaluated every 12 h following
CLP until death. During all experimental procedures, mice
were monitored daily and those that presented impaired
locomotor activity and no struggle response to sequential
handling were euthanized. All experimental procedures
were performed according to the Committee on Ethical
Use of Laboratory Animals of Oswaldo Cruz Foundation
(Fiocruz, Brazil, #L62/12).
Antibody treatment
Hamster anti-TCR γδ (3A10, anti-pan-δ, described by
Itohara et al. [60]) and anti-Vγ4 (UC3-10A6, described
by Dent et al. [61]) monoclonal antibodies (mAb) were
obtained from SCID mice (Oswaldo Cruz Foundation
breeding unit, Rio de Janeiro, Brazil) ascitic fluid. 3A10
preparation was further purified/concentrated by Protein
G (GE Healthcare, USA) affinity chromatography while
UC3 was concentrated by ammonium sulfate precipita-
tion. Both antibody preparations were dialyzed against
saline solution before use. mAbs were i.p. administered
(500 μg/mice every other day for 7 days, starting 1 day
before CLP). Control mice were similarly sham-treated
with normal hamster serum IgG.
Recovery of leukocytes from lung and spleen
Lung tissue samples were obtained from euthanized
C57BL/6 mice at 1, 3, 7 and 10 days after CLP, macer-
ated in RPMI 1640 medium containing collagenase type
IV (250 IU/ml, 37 °C, 30 min) and centrifuged (400 g,
10 min). Spleens were dissected, macerated in PBS con-
taining EDTA (10 mM, pH 7.4), and centrifuged (420 g
for 10 min at 20 °C). Cell pellets from lung and spleen
were re-suspended in 3 ml of PBS/EDTA and subjected
to centrifugation on a Histopaque 1083 gradient (400 g
for 30 min) for mononuclear cell separation.
Flow cytometric analysis
Leukocytes were stained with the appropriate concentration
of the following antibodies: PE/FITC CD3 (145–2C11), PE/
FITC TCR δ chain (GL3), PE TCR β chain (H57–597), FITC
Vγ4 TCR (UC3-10A6), FITC Vδ4 TCR (GL2), FITC CD25
(7D4), PE/FITC IgG1 and IgG2 isotypes (BD Pharmingen,
USA) and APC Vγ1 TCR (2.11) (Biolegend, USA). For intra-
cellular cytokine staining, cells were pre-incubated for 4 h
with PMA (20 ng/ml), ionomycin (500 ng/ml) and brefeldin
A (10 μg/ml) at 37 °C and 5 % CO2. After surface marker
staining, cells were fixed, permeabilized and stained with
anti-IFN-γ, anti-TNF-α, anti-IL-4, anti-IL-10, anti-IL-12 and
anti-IL-17 antibodies (BD Pharmingen, USA). IgG isotypes
were used as irrelevant antibodies. Cells were acquired by
FACScalibur flow cytometer (Becton Dickinson, USA) and
analyzed either by Cell Quest or FlowJo softwares. Counts
are reported as percentage and as numbers of cells after themultiplication of the percentage of T lymphocyte population
by the total number of leukocytes. Gating strategies are
shown in additional files (Additional file 3: Figure S3 and
Additional file 4: Figure S4).Adoptive transfer assay
Naïve C57BL/6 splenocytes were labeled with CFSE
(Invitrogen USA, 1 μM/8×106 cells) and i.v. injected
(4 × 107 cells, ≥ 90 % viability) into recipient mice 3 and
8 days after CLP or sham operations. Recipient mice
were euthanized 10 days after adoptive transfer and their
lungs were recovered for leukocyte analysis.Preparation of lung homogenates
Lung homogenates were prepared by homogenizing per-
fused whole lung tissue using a glass potter homogenizer
(Kontes Glass Company, USA) in 2 ml of PBS containing
cell lysis buffer (Sigma Aldrich, USA) and protease inhibi-
tor (1 μl/ml; Sigma Aldrich, USA), at 4 °C. The homoge-
nates were centrifuged (8400 g for 30 min, 4 °C) and the
supernatants were filtered (0.2 μm). For chemotaxis
assays, lungs were homogenized using PBS only.Cytokine quantification
Levels of chemokines were evaluated in lung homogenates
from lungs recovered 7 days after CLP surgery by sand-
wich enzyme-linked immunosorbent assay (ELISA) by
using matched antibody pairs from R&D (Minneapolis,
MN), according to manufacturer’s instructions. IL-17
quantification was performed using the BD™ Cytometric
Bead Array (CBA) mouse Th1/Th2/Th17 kit (BD Biosci-
ences, USA), and samples were analyzed using a FACSca-
libur flow cytometer.Transwell migration assay
Spleen T lymphocytes (3 × 106 in HBSS without Ca2+/
Mg2+) were placed in the upper chamber of 5.0 μm pore
diameter transwell tissue culture inserts (BD Falcon,
USA). Transwell inserts were placed in the individual
wells of a 24-well cell culture plate containing assay
buffer or lung homogenates from naïve, sham-operated
and CLP-operated mice, neutralized (30 min, 37 °C) with
anti-CCL2 mAb (2.5 ng/well), anti-CCL3 mAb (200 ng/
well) or anti-CCL5 mAb (50 ng/well). The recombinant
chemokines rmCCL2 (2.5 ng/well), rmCCL3 (4 ng/well)
and rmCCL5 (4 ng/well) (R&D Systems, USA) were used
as positive controls. After 2 h, the migrated cells were
counted, labeled as described above, and analyzed by
FACScalibur. Results are expressed as chemotactic index,
generated by using the number of cells that migrated
towards buffer as comparison.
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Data are reported as the mean ± SEM and were statisti-
cally evaluated by analysis of variance (ANOVA) followed
by Newman-Keuls-Student test or Student’s t test. Values
of p ≤ 0.05 were regarded as significant.Additional files
Additional file 1: Figure S1. Cytokine production by γδ T lymphocytes
from the lungs of CLP-operated mice. (A) Percentage of IL-4+, IL-10+, IL-12+,
IFN-γ+ and TNF-α+ γδ T lymphocytes obtained from the lungs of C57BL/6
mice 10 days after CLP or sham surgery. Cells were cultured with brefeldin
A (10 μg/ml, 4 h), submitted to intracellular staining and analyzed by
flow cytometry. Results are expressed as mean ± SEM from at least 4 animals
per experimental group. (B) Percentage of IL-17+ and (C) IFN-γ+ γδ T
lymphocytes within the population of splenic γδ T lymphocytes recovered
10 days after CLP, stimulated ex-vivo with α-CD3 mAb (5 μg/ml, 4 h),
submitted to intracellular staining and analyzed by flow cytometry. Statistical
differences between the CLP or α-CD3-stimulated groups and the negative
control groups (p < 0.05) are indicated by (*). Gates were established after
the staining with their IgG isotypes.
Additional file 2: Figure S2. γδ T cell depletion induced by α-γδ mAb
(3A10) administration. To certify the effectiveness of α-γδ mAb treatment,
γδ TCR staining was performed in permeabilized cells recovered from
C57BL/6 mouse spleens after α-γδ TCR mAb (3A10) or hamster serum IgG
administration. (A) Representative dot plots of intracellular γδ TCR staining
with UC7 (Southern Biotech, USA) and GL3 (Caltag, UK) mAbs in αβ-/B220-
cell population. (B) Representative histograms of intracellular γδ TCR staining
(GL3 mAb) of αβ-/B220- cells recovered from α-γδ TCR mAb (3A10) or
hamster serum IgG-treated mouse, placed in culture for 48 h.
Additional file 3: Figure S3. Gating strategies used for FACS analysis
of γδ and αβ T lymphocytes. A lymphocyte gate (R1) was defined based
on the cells’ Forward Scatter (FSC) and Side Scatter (SSC), further gated
on TCRγδ+ (R2) or αβ+ (R3) lymphocytes.
Additional file 4: Figure S4. Gating strategies used for FACS analysis
of γδ and αβ T lymphocytes within IL-17+ cells. IL-17+ lymphocyte gate
(R6) was defined and further gated on TCRγδ+ and αβ+ lymphocytes.
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